The United States must press the Syrian Transitional Government to bring the perpetrators of the Saint Elias Church attack to ...

Daily thought The Lord said to Ananias, “Get up and go to Straight Street. Find the house of Judas, and ask for a man named Saul from the city of Tarsus. He is there now, praying. Saul has seen a ...

Discover showtimes, read reviews, watch trailers, find streaming options, and see where to watch Saul of Tarsus (1990). Explore cast details and learn more on Moviefone.

Tarsus Pharmaceuticals (NASDAQ:TARS) is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors need to know before the announcement. Analysts estimate that ...

Oppenheimer assumed coverage of Tarsus Pharmaceuticals (TARS) with an Outperform rating with a price target of $75, up from $72. The firm notes the company reported Q1 2025 topline of $78.3M ...

Tarsus Pharmaceuticals' lotilaner shows strong market performance for Demodex blepharitis, but cautious investment due to lack of near-term catalysts. Read more here.

In trading on Tuesday, shares of Tarsus Pharmaceuticals Inc (Symbol: TARS) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $39.25 per share.

Roughly one year since the commercial rollout of Tarsus Pharmaceuticals’ first marketed product Xdemvy, the company is touting the medicine’s debut as “one of the most successful eye care ...

A majority of patients pay $50 or less for Xdemvy A week before Tarsus Pharmaceuticals received federal approval for its groundbreaking treatment of an eyelid inflammation that impacts 25 million ...

Tarsus CEO Bobby Azamian, along his executive team and his wife, Blair, and their 6-week-old newborn, Auggie, ring the closing bell at Nasdaq Shares of Tarsus Pharmaceuticals Inc. rose 15% in ...